using a DNeasy Plant Mini Kit (Qiagen), according to the manufacturer's protocol with minor modifications.
PCR Amplification Polymerase chain reaction (PCR) was performed using 30-100 ng of total DNA as the template in 25 ml of a reaction mixture containing 2.5 ml 10ϫPCR buffer for KOD-Plus-, 0.2 mM of each dNTP, 1.0 mM of MgSO 4 , 0.5 units KOD-Plus-polymerase (Toyobo), and 0.4 mM of each primer. Primers used are shown in Table  2 . Amplification was carried out under the following conditions: pre-heating at 94°C for 2 min; 30 cycles of denaturation at 94°C for 15 s, annealing at 55°C for 30 s and elongation at 68°C for 2 min; a final elongation at 68°C for 5 min. One tenth volume of the PCR products was analyzed by agarose gel electrophoresis and then the remaining part was purified using a QIAquick PCR Purification Kit (Qiagen).
Sequencing Reaction The purified PCR product was subjected to direct sequencing using a BigDye Terminator Cycle Sequencing Kit (Applied Biosystems) using an ABI PRISM 310 sequencer (Applied Biosystem). The DNA sequences were aligned using 'DNASIS' version 3.0 (Hitachi).
Cloning of PCR Products Total DNA of Shikoku and Yunnan-1, were amplified by using a tagged primer set, p and q. Those of L2 and Korea-2, were amplified by using primer set, p and i, and those with combined sequences in the 28S rRNA gene, L2, Shikoku and Yunnan-1, were amplified by using primer sets h and j or r and s. After purification using a QIAquick PCR purification kit, the PCR products (100-200 ng) were digested with BamHI and HindIII (TaKaRa) in a 10 ml-reaction reaction mixture containing 20 mM Tris-HCl (pH 8.5), 10 mM MgCl 2 , 1 mM dithiothreitol, and 0.1 M KCl at 37°C for 1 h, and then the reaction mixture was heated to 70°C for 15 min. Four microliters of the reaction mixtures were combined with 5 ng of pBluescript SK(Ϫ)plasmid digested with the same enzymes and 5 ml of DNA Ligation Kit Ver.2.1 (TaKaRa). The ligation reaction was performed at 16°C overnight. Competent cells (Competent high DH5a, TOYOBO) were transformed with the ligated product according to the manufacturer's protocol. The transformed cells were spread on LB/Amp plates (2% tripton, 1% yeast extract, 2% NaCl, 3% agar, and 10 mg/ml ampicillin) and incubated at 37°C overnight. Bacterial colonies were picked up separately, and sub-cultured in liquid LB/Amp medium. After overnight-incubation, the bacteria were collected by centrifugation and plasmids were obtained according to a standard protocol. 8) Restriction Fragment Length Polymorphism Experiment for the Discrimination of Group-1, -2, and -3 PCR 
products amplified by using primer sets of k and o or k and l were purified using a QIAquick PCR purification kit and then digested with 15 units of restriction enzyme either BamHI or DraI (Takara) at 37°C for 1 h. Reaction mixtures were separated by electrophoresis in 2% agarose gels with 1ϫTAE buffer. After 1 h immersion in 0.5 ng/ml ethidium bromide solution, the digested products were visualized under UV light and photographed.
RESULTS

Sequencing Analysis of the ITS Regions
Direct sequencing of PCR products of the ITS 1 and 2 regions revealed that 16 of 20 Poria cocos samples (the exceptions were L2, Shikoku, Korea-2, and Yunnan-1) had identical sequences with the nucleotide lengths of 997 bps and 460 bps, respectively ( Table 3 ). By cloning the PCR products of L2, Shikoku, Korea-2, and Yunnan-1, they were found to have overlapping of the common sequence and sequences with 1 or 2 base-pair-insertions; a 2 base-pair-insertion at nucleotide positions 637-638 of ITS1 in Yunnan-1, and 1 base-pair-insertions at nucleotide position 419 of ITS2 in L2, at nucleotide position 657 of ITS1 in Shikoku, and at nucleotide position 453 of ITS2 in Korea-2. Altogether, the nucleotide lengths of ITS 1 and 2 of these Poria cocos samples were substantially longer in comparison with other fungus crude drugs, such as Ganoderma lucidum and Polyporu umbellatus; the lengths of their ITS 1 and 2 sequences were reported within the ranges of 190-220 bps and 170-200 bps, respectively. [9] [10] [11] [12] When the PCR products amplified from the ITS 1 region using primer set a and d of the Poria cocos samples and those of Ganoderma lucidum and Polyporus umbellatus were compared, they could be clearly distinguished from each other by agarose gel electrophoresis (Fig.  1) .
Sequencing Analysis of 28S rRNA Gene About nine tenths of the 28S rRNA gene sequence was determined by the nucleotide sequence alignment of PCR products amplified using primer sets g and j, k and m, and n and o. The results revealed that the nucleotide length of this region varied as shown in Table 3 . By cloning the PCR products, the 28S rRNA gene sequence of 2 Japanese samples, L2 and Shikoku, and Yunnan-1 (Yunnan) were found to have overlapping of the common sequence with 2865 bps and sequences with insertions, a 3-base-pair insertion at nucleotide positions 2166-2168 in L2 and Shikoku, and a 1 base-pair insertion at nucleotide positions 611 in Yunnan-1. Some examples of deletions and mutations are shown in Table 4 . The sequences of 14 samples listed from the top in tutions were found. Among these substitutions, the nucleotide positions 1130-1135 of Group III were TTTAAA, the recognition site of DraI, and that of Group I and II were TTTGAA. Furthermore, the nucleotide positions 2001-2006 of Group I were AGATCC, whereas those of Group II and III were GGATCC, the recognition site of BamHI. Using BamHI or DraI, the restriction fragment length polymorphisms (RFLP) of the groups can be observed, as shown in Figs. 2 and 3 . Thus, the discrimination of 3 groups could be achieved by the combination of RFLPs. Group I could be Sample name 611  690  1058  1106  1168  1467 1642-1643 1654-1655 1714  1785-1787  2082   K1  -A  C  T  -T  TC  CC  G  CGC  T  I2 further classified by a notable substitution at nucleotide position 690. All Japanese samples, Korea-2 (Korean Peninsula), and Yunnan-1 (Yunnan) had adenine at this position, which made a restriction site for DraI (TTTAAA), whereas Sekkou-1 and -2 (Zhejiang) and Kishu (Guizhou) had guanine, and Anki-2 (Anhui), Yunnan-3, and Yunnan-4 (Yunnan) had adenine and guanine (Table 4 ). When PCR products amplified from the samples using primer set h and i were digested with DraI, these subgroups of Group I with adenine were digested whereas those with guanine remained intact and with adenine and guanine showed digested and intact signals. Thus, the subgroups could be also distinguished by this RFLP (Fig. 4) .
DISCUSSION
We determined the DNA sequences of ITS 1, the 5.8S rRNA gene, ITS 2, and most of the 28S rRNA gene of Poria cocos for the first time. Other fungal crude drugs that belong to the Polyporaceae, Ganoderma lucidum, and Polyporus umbellatus, were reported to have various substitutions in ITS 1 and 2. [9] [10] [11] [12] Although the nucleotide lengths of ITS 1 and 2 of Poria cocos samples were remarkably longer than Ganoderma and Polyporus, they preserved almost identical sequences in these regions. Some of the Poria cocos samples possessed combined sequences, their sequences were combinations of the common sequences and those with insertions of 1-3 bps at single sites. Thus, ITS 1 and ITS 2 of Poria cocos were quite different from Ganoderma lucidum and Polyporus umbellatus in nucleotide length as well as in homogeneity. The first fifth of the 28S rRNA gene of the Poria cocos samples, except position 690, was also homologous and was similar to the Ganoderma sequence. On the other hand, the other part of the 28S rRNA gene could be divided in 3 groups (Group 1, 2, 3) with distinct differences in length and in nucleotide sequence. All of the Japanese cultured mycelia samples were classified in Group 1, while the crude drugs from China and Korean Peninsula included products of different genotypes. Among the Yunnan samples, for example, Yunnan-1, Yunnan-3, and Yunnan-4 had their genotypes classified in Group 1, whereas Yunnan-2 was in Group 2. Similarly, 3 cultivated Anhui samples had genotypes classified in different groups; Anki-2 in Group 1, and Anki-1 and -3 in Group 3. These results suggest not only that there are crude drugs with a variety of genotypes but also that the current locality of the crude drugs does not guarantee genetic uniformity. The inhibitory activity of beta-glucan of Hoelen on cancer cells, one of the newly recognized therapeutic potentials of the crude drug, seemed to be different between strains. 13) The traditional concept of quality as well as recently recognized efficacy of the crude drug must be discussed when considering their genotype. These results of DNA typing of Poria cocos and the methods we propose here will help to discriminate of the quality of the crude drug by genotype.
